Experiences of two centers in percutaneous ventricular septal defect closure using konar multifunctional occluder
Göster/ Aç
Erişim
info:eu-repo/semantics/openAccessAttribution-NonCommercial 4.0 Internationalhttps://creativecommons.org/licenses/by-nc/4.0/Tarih
2022Yazar
Kamalı, HacerSivaslı Gül, Özlem
Çoban, Şenay
Sarı, Gizem
Sarıtaş, Türkay
Erdem, Abdullah
Aldudak, Bedri
Üst veri
Tüm öğe kaydını gösterKünye
Kamalı, H., Sivaslı Gül, Ö., Çoban, Ş., Sarı, G., Sarıtaş, T., Erdem, A. ... Aldudak, B. (2022). Experiences of two centers in percutaneous ventricular septal defect closure using konar multifunctional occluder. Anatolian Journal of Cardiology, 26(4), 276-285. https://doi.org/10.5152/AnatolJCardiol.2021.464Özet
BACKGROUND: Transcatheter closure of perimembraneous ventricular septal defect still poses a challenge due to the adjacent structures of the tricuspid and aortic valves and the risk of atrioventricular block. We report our experience at 2 centers using the KONAR-MF (multifunctional occluder) ventricular septal defect device, which gained its CE mark in May 2018. METHODS: A retrospective study was carried out on all patients who underwent transcatheter ventricular septal defect closure with the KONAR-MF (multifunctional occluder) ventricular septal defect device at 2 centers. RESULTS: A total of 47 patients were identified. The median age and weight of the patients were 25.8 months and 11 kg. The ventricular septal defects that were closed in 5 cases were post-operative hemodynamically significant residual ventricular septal defects. Forty-eight devices were used in the 47 cases. As for the location of the ventricular septal defect, 40/48 (83.33%) ventricular septal defects were perimembranous and 8/48 (16.66%) were muscular. The percutaneous device closure was successful in 46 procedures (95.8%). Device embolization was observed in 2 patients, and a significant residual shunt was observed in 2 cases. In the follow-up, there was no enhancement in the residual shunt in the remaining cases. Temporary atrioventricular block occurred in 2 cases during the procedure and improved after long sheath withdrawal. CONCLUSION: Soft, flexible, and low-profile KONAR-MF (multifunctional occluder) occluders ensure easy and safe implantation, and small sheath sizes allow for their use in small infants. Although near and mid-term follow-ups did not indicate any permanent atrioventricular block, a larger sample of patients and a longer follow-up period is necessary to understand long-term outcomes.